Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis

A melanoma, immunosuppressive technology used in the field of diagnosis of an array of diseases or conditions, addressing exposure, life-threatening infection and malignancy

Inactive Publication Date: 2009-12-09
BAYLOR RES INST
View PDF16 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although severe immunosuppression resulting from pharmacologic therapy is necessary for maintenance of graft survival and function, it also exposes recipients to life-threatening infections and malignancies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
  • Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
  • Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0654] Example 2. Identification of ubiquitous and disease-specific gene expression markers in peripheral blood leukocytes of patients using significance pattern determination and analysis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention includes compositions, systems and methods for the early detection and consistent determination of metastatic melanoma and / or immunosuppression using microarrays by calculating one or more expression vectors from the expression of one or more genes.

Description

[0001] technical field of invention [0002] The present invention relates generally to the field of diagnostics for monitoring indicators of metastatic melanoma and / or immunosuppression, and more particularly to the diagnosis, prognosis and tracking of metastatic melanoma and monitoring and transplantation Systems, methods, and devices for indicators of recipient (eg, liver)-associated immunosuppression. [0003] long form [0004] This patent application contains long tabular sections. A copy of the form can be obtained electronically from the USPTO website (http: / / seqdata.uspto.gov / ). Electronic copies of the forms are also available from the USPTO upon request and payment of the fee described in 37 CFR 1.19(b)(3). Background of the invention [0005] This application claims priority to US Provisional Patent Application Serial No. 60 / 748,884, filed December 9, 2005, which is incorporated herein by reference in its entirety. Without limiting the scope of the invention, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G06F19/00C12Q1/68G11C17/00G16B25/10G16B20/20
CPCG06F19/20C12Q1/6837C12Q2600/158C12Q1/6886G06F19/18G16B20/00G16B25/00G16B20/20G16B25/10G16B45/00
Inventor A·K·帕露卡J·F·班彻罗D·肖萨贝尔
Owner BAYLOR RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products